First-year treatment response predicts the following 5-year disease course in patients with relapsing-remitting multiple sclerosis.
Saved in:
| Title: | First-year treatment response predicts the following 5-year disease course in patients with relapsing-remitting multiple sclerosis. |
|---|---|
| Authors: | Toscano S; Department of Biomedical and Biotechnological Sciences, University of Catania, Via Santa Sofia 78, 95123 Catania, Italy; Multiple Sclerosis Unit, University-Hospital G. Rodolico - San Marco, Catania, Italy., Spelman T; MSBase Foundation, VIC, Melbourne, Australia; Department of Clinical Neuroscience, Karolinska Institute, Stockholm, Sweden., Ozakbas S; Dokuz Eylul University, Konak, Izmir, Turkey., Alroughani R; Division of Neurology, Department of Medicine, Amiri Hospital, Sharq 73767, Kuwait., Chisari CG; Multiple Sclerosis Unit, University-Hospital G. Rodolico - San Marco, Catania, Italy; Department of Medical and Surgical Sciences and Advanced Technologies, GF Ingrassia, Catania 95123, Italy., Lo Fermo S; Multiple Sclerosis Unit, University-Hospital G. Rodolico - San Marco, Catania, Italy; Department of Medical and Surgical Sciences and Advanced Technologies, GF Ingrassia, Catania 95123, Italy., Prat A; CHUM MS Center and Universite de Montreal, Montreal H2L 4M1, Canada., Girard M; CHUM MS Center and Universite de Montreal, Montreal H2L 4M1, Canada., Duquette P; CHUM MS Center and Universite de Montreal, Montreal H2L 4M1, Canada., Izquierdo G; Hospital Universitario Virgen Macarena, Sevilla 41009, Spain., Eichau S; Hospital Universitario Virgen Macarena, Sevilla 41009, Spain., Grammond P; CISSS Chaudière-Appalache, Levis G6X 0A1, Canada., Boz C; KTU Medical Faculty Farabi Hospital, Trabzon 61080, Turkey., Kalincik T; CORe, Department of Medicine, The University of Melbourne, Melbourne 3050, Australia; Neuroimmunology Centre, Department of Neurology, Royal Melbourne Hospital, Melbourne 3050, Australia., Blanco Y; Center of Neuroimmunology, Service of Neurology, Hospital Clinic de Barcelona, Barcelona, Spain., Buzzard K; Department of Neurology, Box Hill Hospital, Melbourne 3128, Australia., Skibina O; Department of Neurology, Box Hill Hospital, Melbourne 3128, Australia., Sa MJ; Department of Neurology, Centro Hospitalar Universitario de Sao Joao, Porto 4200-319, Portugal; Faculty of Health Sciences, University Fernando Pessoa, Porto, Portugal., van der Walt A; Department of Neurology, The Alfred Hospital, Melbourne 3000, Australia., Butzkueven H; Department of Neurology, The Alfred Hospital, Melbourne 3000, Australia., Terzi M; Medical Faculty, 19 Mayis University, Samsun 55160, Turkey., Gerlach O; Academic MS Center Zuyd, Department of Neurology, Zuyderland Medical Center, Sittard-Geleen 5500, the Netherlands; School for Mental Health and Neuroscience, Department of Neurology, Maastricht University Medical Center, Maastricht 6131 BK, the Netherlands., Grand'Maison F; Neuro Rive-Sud, Quebec J4V 2J2, Canada., Foschi M; Department of Neuroscience, Multiple Sclerosis Center, Neurology Unit, S. Maria delle Croci Hospital, AUSL Romagna, Ravenna, Italy; Department of Biotechnological and Applied Clinical Sciences, University of L'Aquila, L'Aquila, Italy., Surcinelli A; Department of Neuroscience, Multiple Sclerosis Center, Neurology Unit, S. Maria delle Croci Hospital, AUSL Romagna, Ravenna, Italy., Barnett M; Brain and Mind Centre, Sydney 2050, Australia., Lugaresi A; IRCCS Istituto delle Scienze Neurologiche di Bologna, Bologna, Italy; Department of Biomedical and Neuromotor Science, University of Bologna, Bologna, Italy., Onofrj M; Department of Neuroscience, Imaging, and Clinical Sciences, University G. D'Annunzio, Chieti 66013, Italy., Yamout B; Nehme and Therese Tohme Multiple Sclerosis Center, American University of Beirut Medical Center, Beirut 1107 2020, Lebanon., Khoury SJ; Nehme and Therese Tohme Multiple Sclerosis Center, American University of Beirut Medical Center, Beirut 1107 2020, Lebanon., Prevost J; CSSS Saint-Jérôme, Saint-Jerome J7Z 5T3, Canada., Lechner-Scott J; School of Medicine and Public Health, University Newcastle, Newcastle 2305, Australia., Maimone D; Centro Sclerosi Multipla, Garibaldi Hospital, Catania 95124, Italy., Amato MP; Department NEUROFARBA, University of Florence, Florence 50134, Italy; IRCCS Fondazione Don Carlo Gnocchi, Florence, Italy., Spitaleri D; Azienda Ospedaliera di Rilievo Nazionale San Giuseppe Moscati Avellino, Avellino 83100, Italy., Van Pesch V; Department of Neurology, Cliniques Universitaires Saint-Luc, Université Catholique de Louvain (UCLouvain), Brussels, Belgium., Macdonell R; Austin Health, Melbourne 3084, Australia., Cartechini E; AST 3 Macerata, Marche, Italy., de Gans K; Department of Neurology, Groene Hart Ziekenhuis, Gouda, Zuid-Holland, the Netherlands., Slee M; Flinders University, Adelaide 5042, Australia., Castillo-Triviño T; Hospital Universitario Donostia and IIS Biodonostia, San Sebastián, Spain., Soysal A; Bakirkoy Education and Research Hospital for Psychiatric and Neurological Diseases, Istanbul 34147, Turkey., Sanchez-Menoyo JL; Department of Neurology, Galdakao-Usansolo University Hospital, Osakidetza-Basque Health Service, Biocruces, Spain., Laureys G; Department of Neurology, Ghent Universitary Hospital, Ghent 9000, Belgium., Van Hijfte L; Department of Neurology, Ghent Universitary Hospital, Ghent 9000, Belgium., McCombe P; Royal Brisbane and Women's Hospital, University of Queensland, Brisbane 4000, Australia., Altintas A; Department of Neurology, School of Medicine, Koc University, Koc University Research Center for Translational Medicine (KUTTAM), Istanbul 34450, Turkey., Weinstock-Guttman B; Department of Neurology, Buffalo General Medical Center, Buffalo 14202, United States., Aguera-Morales E; University Hospital Reina Sofia, Cordoba 14004, Spain., Etemadifar M; Department of Neurosurgery, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran., Ramo-Tello C; Hospital Germans Trias i Pujol, Badalona 08916, Spain., John N; Department of Medicine, School of Clinical Sciences, Monash University, Clayton, Australia; Department of Neurology, Monash Health, Clayton, Australia., Turkoglu R; Haydarpasa Numune Training and Research Hospital, Istanbul 34668, Turkey., Hodgkinson S; Liverpool Hospital, Sydney 2170, Australia., Besora S; Hospital Universitari Mútua de Terrassa, Barcelona, Spain., Van Wijmeersch B; Universitair MS Centrum, Hasselt University, Hasselt-Pelt, Belgium; Rehabilitation & MS Centre, Pelt, Belgium., Fernandez-Bolaños R; Department of Neurology, Hospital Universitario Virgen de Valme, Spain., Patti F; Multiple Sclerosis Unit, University-Hospital G. Rodolico - San Marco, Catania, Italy; Department of Medical and Surgical Sciences and Advanced Technologies, GF Ingrassia, Catania 95123, Italy. Electronic address: francesco.patti@unict.it. |
| Corporate Authors: | MSBase Study Group |
| Source: | Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics [Neurotherapeutics] 2025 Mar; Vol. 22 (2), pp. e00552. Date of Electronic Publication: 2025 Feb 17. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Elsevier Inc. on behalf of American Society for Experimental NeuroTherapeutics Country of Publication: United States NLM ID: 101290381 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1878-7479 (Electronic) Linking ISSN: 18787479 NLM ISO Abbreviation: Neurotherapeutics Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
